Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats

Yasuaki Kanada, Ayami Katayama, Hideshi Ikemoto, Kana Takahashi, Mana Tsukada, Akio Nakamura, Shogo Ishino, Tadashi Hisamitsu, Masataka Sunagawa Department of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo, Japan Objectives: Irritable bowel syndrome (IBS) is a functional gas...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kanada Y, Katayama A, Ikemoto H, Takahashi K, Tsukada M, Nakamura A, Ishino S, Hisamitsu T, Sunagawa M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/e852aa368b924ba7862b719fc3bb3da4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e852aa368b924ba7862b719fc3bb3da4
record_format dspace
spelling oai:doaj.org-article:e852aa368b924ba7862b719fc3bb3da42021-12-02T07:44:14ZInhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats1178-2021https://doaj.org/article/e852aa368b924ba7862b719fc3bb3da42018-04-01T00:00:00Zhttps://www.dovepress.com/inhibitory-effect-of-the-kampo-medicinal-formula-yokukansan-on-acute-s-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Yasuaki Kanada, Ayami Katayama, Hideshi Ikemoto, Kana Takahashi, Mana Tsukada, Akio Nakamura, Shogo Ishino, Tadashi Hisamitsu, Masataka Sunagawa Department of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo, Japan Objectives: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder with symptoms of abnormal defecation and abdominal discomfort. Psychological factors are well known to be involved in onset and exacerbation of IBS. A few studies have reported effectiveness of traditional herbal (Kampo) medicines in IBS treatment. Yokukansan (YKS) has been shown to have anti-stress and anxiolytic effects. We investigated the effect of YKS on defecation induced by stress and involvement of oxytocin (OT), a peptide hormone produced by the hypothalamus, in order to elucidate the mechanism of YKS action. Methods and results: Male Wistar rats were divided into four groups; control, YKS (300 mg/kg PO)-treated non-stress (YKS), acute stress (Stress), and YKS (300 mg/kg PO)-treated acute stress (Stress+YKS) groups. Rats in the Stress and Stress+YKS groups were exposed to a 15-min psychological stress procedure involving novel environmental stress. Levels of plasma OT in the YKS group were significantly higher compared with those in the Control group (P < 0.05), and OT levels in the Stress+YKS group were remarkably higher than those in the other groups (P < 0.01). Next, rats were divided into four groups; Stress, Stress+YKS, Atosiban (OT receptor antagonist; 1 mg/kg IP)-treated Stress+YKS (Stress+YKS+B), and OT (0.04 mg/kg IP)-treated acute stress (Stress+OT) groups. Rats were exposed to acute stress as in the previous experiment, and defecation during the stress load was measured. Administration of YKS or OT significantly inhibited defecation; however, administration of Atosiban partially abolished the inhibitory effect of YKS. Finally, direct action of YKS on motility of isolated colon was assessed. YKS (1 mg/mL, 5 mg/mL) did not inhibit spontaneous contraction. Conclusion: These results suggested that YKS influences stress-induced defecation and that increased OT secretion may be a mechanism underlying this phenomenon. Keywords: Yokukansan, oxytocin, irritable bowel syndrome, acute stress, corticosterone, Kampo medicineKanada YKatayama AIkemoto HTakahashi KTsukada MNakamura AIshino SHisamitsu TSunagawa MDove Medical PressarticleYokukansanoxytocinirritable bowel syndromeacute stresscorticosteroneKampo medicineNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 937-944 (2018)
institution DOAJ
collection DOAJ
language EN
topic Yokukansan
oxytocin
irritable bowel syndrome
acute stress
corticosterone
Kampo medicine
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Yokukansan
oxytocin
irritable bowel syndrome
acute stress
corticosterone
Kampo medicine
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Kanada Y
Katayama A
Ikemoto H
Takahashi K
Tsukada M
Nakamura A
Ishino S
Hisamitsu T
Sunagawa M
Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
description Yasuaki Kanada, Ayami Katayama, Hideshi Ikemoto, Kana Takahashi, Mana Tsukada, Akio Nakamura, Shogo Ishino, Tadashi Hisamitsu, Masataka Sunagawa Department of Physiology, School of Medicine, Showa University, Shinagawa-ku, Tokyo, Japan Objectives: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder with symptoms of abnormal defecation and abdominal discomfort. Psychological factors are well known to be involved in onset and exacerbation of IBS. A few studies have reported effectiveness of traditional herbal (Kampo) medicines in IBS treatment. Yokukansan (YKS) has been shown to have anti-stress and anxiolytic effects. We investigated the effect of YKS on defecation induced by stress and involvement of oxytocin (OT), a peptide hormone produced by the hypothalamus, in order to elucidate the mechanism of YKS action. Methods and results: Male Wistar rats were divided into four groups; control, YKS (300 mg/kg PO)-treated non-stress (YKS), acute stress (Stress), and YKS (300 mg/kg PO)-treated acute stress (Stress+YKS) groups. Rats in the Stress and Stress+YKS groups were exposed to a 15-min psychological stress procedure involving novel environmental stress. Levels of plasma OT in the YKS group were significantly higher compared with those in the Control group (P < 0.05), and OT levels in the Stress+YKS group were remarkably higher than those in the other groups (P < 0.01). Next, rats were divided into four groups; Stress, Stress+YKS, Atosiban (OT receptor antagonist; 1 mg/kg IP)-treated Stress+YKS (Stress+YKS+B), and OT (0.04 mg/kg IP)-treated acute stress (Stress+OT) groups. Rats were exposed to acute stress as in the previous experiment, and defecation during the stress load was measured. Administration of YKS or OT significantly inhibited defecation; however, administration of Atosiban partially abolished the inhibitory effect of YKS. Finally, direct action of YKS on motility of isolated colon was assessed. YKS (1 mg/mL, 5 mg/mL) did not inhibit spontaneous contraction. Conclusion: These results suggested that YKS influences stress-induced defecation and that increased OT secretion may be a mechanism underlying this phenomenon. Keywords: Yokukansan, oxytocin, irritable bowel syndrome, acute stress, corticosterone, Kampo medicine
format article
author Kanada Y
Katayama A
Ikemoto H
Takahashi K
Tsukada M
Nakamura A
Ishino S
Hisamitsu T
Sunagawa M
author_facet Kanada Y
Katayama A
Ikemoto H
Takahashi K
Tsukada M
Nakamura A
Ishino S
Hisamitsu T
Sunagawa M
author_sort Kanada Y
title Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
title_short Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
title_full Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
title_fullStr Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
title_full_unstemmed Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
title_sort inhibitory effect of the kampo medicinal formula yokukansan on acute stress-induced defecation in rats
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/e852aa368b924ba7862b719fc3bb3da4
work_keys_str_mv AT kanaday inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT katayamaa inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT ikemotoh inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT takahashik inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT tsukadam inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT nakamuraa inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT ishinos inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT hisamitsut inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
AT sunagawam inhibitoryeffectofthekampomedicinalformulayokukansanonacutestressinduceddefecationinrats
_version_ 1718399252926824448